Heska Corporation (HSKA): Price and Financial Metrics


Heska Corporation (HSKA): $160.96

-4.49 (-2.71%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

HSKA POWR Grades


  • Value is the dimension where HSKA ranks best; there it ranks ahead of 60.47% of US stocks.
  • The strongest trend for HSKA is in Stability, which has been heading up over the past 52 weeks.
  • HSKA's current lowest rank is in the Growth metric (where it is better than 2.87% of US stocks).

HSKA Stock Summary

  • With a price/earnings ratio of 947.12, Heska Corp P/E ratio is greater than that of about 99.18% of stocks in our set with positive earnings.
  • The price/operating cash flow metric for Heska Corp is higher than 97.3% of stocks in our set with a positive cash flow.
  • With a year-over-year growth in debt of 82.8%, Heska Corp's debt growth rate surpasses 89.46% of about US stocks.
  • If you're looking for stocks that are quantitatively similar to Heska Corp, a group of peers worth examining would be BMRN, OPRX, RDVT, CELH, and RMBS.
  • Visit HSKA's SEC page to see the company's official filings. To visit the company's web site, go to www.heska.com.

HSKA Valuation Summary

  • In comparison to the median Healthcare stock, HSKA's price/sales ratio is 1.32% higher, now standing at 11.5.
  • HSKA's price/sales ratio has moved up 10.6 over the prior 243 months.
  • HSKA's price/earnings ratio has moved down 1945.6 over the prior 243 months.

Below are key valuation metrics over time for HSKA.

Stock Date P/S P/B P/E EV/EBIT
HSKA 2021-08-31 11.5 6.5 -1947.7 10302.7
HSKA 2021-08-30 11.2 6.4 -1901.9 10045.9
HSKA 2021-08-27 11.4 6.5 -1939.4 10256.0
HSKA 2021-08-26 11.4 6.5 -1942.2 10271.8
HSKA 2021-08-25 11.6 6.6 -1976.3 10462.5
HSKA 2021-08-24 11.8 6.7 -2013.1 10668.7

HSKA Growth Metrics

  • Its 4 year cash and equivalents growth rate is now at 2994.58%.
  • Its 4 year net cashflow from operations growth rate is now at -176.16%.
  • The 3 year price growth rate now stands at 112.19%.
Over the past 33 months, HSKA's revenue has gone up $122,547,000.

The table below shows HSKA's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 249.993 12.717 1.871
2021-06-30 246.389 19.593 -1.45
2021-03-31 227.173 5.442 -7.24
2020-12-31 197.323 -0.656 -14.399
2020-09-30 166.769 -1.529 -18.592
2020-06-30 141.37 -4.443 -13.683

HSKA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • HSKA has a Quality Grade of C, ranking ahead of 66.81% of graded US stocks.
  • HSKA's asset turnover comes in at 0.51 -- ranking 81st of 682 Pharmaceutical Products stocks.
  • NEOG, CLVS, and FLXN are the stocks whose asset turnover ratios are most correlated with HSKA.

The table below shows HSKA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.510 0.417 0.001
2021-03-31 0.525 0.411 -0.016
2020-12-31 0.522 0.412 -0.049
2020-09-30 0.492 0.423 -0.050
2020-06-30 0.473 0.430 -0.055
2020-03-31 0.504 0.447 -0.033

HSKA Price Target

For more insight on analysts targets of HSKA, see our HSKA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $282.50 Average Broker Recommendation 1.6 (Moderate Buy)

HSKA Stock Price Chart Interactive Chart >

Price chart for HSKA

HSKA Price/Volume Stats

Current price $160.96 52-week high $275.94
Prev. close $165.45 52-week low $121.50
Day low $159.47 Volume 60,600
Day high $168.87 Avg. volume 69,853
50-day MA $221.24 Dividend yield N/A
200-day MA $216.68 Market Cap 1.72B

Heska Corporation (HSKA) Company Bio


Heska Corporation sells advanced veterinary diagnostic and other specialty veterinary products, including blood testing instruments and supplies, digital imaging products, software and services, and single-use products and services such as in-clinic heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing. The company was founded in 1988 and is based in Loveland, Colorado.


HSKA Latest News Stream


Event/Time News Detail
Loading, please wait...

HSKA Latest Social Stream


Loading social stream, please wait...

View Full HSKA Social Stream

Latest HSKA News From Around the Web

Below are the latest news stories about Heska Corp that investors may wish to consider to help them evaluate HSKA as an investment opportunity.

Heska (NASDAQ:HSKA) Could Easily Take On More Debt

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Yahoo | November 28, 2021

Heska Corporation (HSKA) Q3 2021 Earnings Call Transcript

HSKA earnings call for the period ending September 30, 2021.

Yahoo | November 4, 2021

Heska Corporation Reports Third Quarter 2021 Results

Heska Corporation (NASDAQ: HSKA; "Heska" or "Company"), a leading provider of advanced veterinary diagnostic and specialty products, reported financial results in two segments (North America and International) for its third quarter ended September 30, 2021. In this release, Point of Care is "POC", Pharmaceuticals, Vaccines and Diagnostics is "PVD", Other Vaccines and Pharmaceuticals is "OVP", contract subscription value is "CSV", practice information management software is "PIMS", Biotech Labora

Yahoo | November 4, 2021

Heska Corporation to Acquire VetZ GmbH, European Leader in Practice Information Management Software Solutions

Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty products, announced today that the Company has entered a definitive agreement (the "Agreement") to acquire 100% of VetZ GmbH ("VetZ"), a European leader in veterinary practice information management software solutions ("PIMS") (such transaction, the "Acquisition").

Yahoo | November 2, 2021

7 A-Rated Healthcare Stocks to Buy for the Long Haul

It looks like we're on the back end of the Covid pandemic, so it's a good time to look at healthcare stocks that have a big future.

Louis Navellier and the InvestorPlace Research Staff on InvestorPlace | November 1, 2021

Read More 'HSKA' Stories Here

HSKA Price Returns

1-mo -28.18%
3-mo -40.97%
6-mo -18.11%
1-year 29.85%
3-year 54.80%
5-year 146.64%
YTD 10.51%
2020 51.81%
2019 11.43%
2018 7.34%
2017 12.03%
2016 85.11%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8504 seconds.